The rapid adoption of digital healthcare technologies in Cambodia is transforming how medical devices operate, communicate, and deliver clinical outcomes. As devices increasingly connect to hospital networks, cloud platforms, mobile applications, and IoMT ecosystems, cybersecurity risks have grown significantly. A single vulnerability can compromise patient safety, alter clinical data, or disrupt medical operations.
To address these risks, the U.S. FDA now requires all medical device manufacturers seeking 510(k) clearance to implement robust cybersecurity controls, documented testing evidence, and risk mitigation measures. Cyberintelsys, a CREST-accredited medical device cybersecurity company supporting clients across Cambodia, provides advanced FDA 510(k) cybersecurity assessments, VAPT, and compliance readiness services tailored to healthcare and medical device manufacturers.
Why FDA 510(k) Cybersecurity Is Essential for Medical Device Manufacturers?
The FDA’s latest premarket cybersecurity guidance mandates that manufacturers demonstrate device security, resilience, and protection against cyber threats. Cybersecurity is now a mandatory component of the 510(k) submission process.
1. Patient Safety
Cyber vulnerabilities can disrupt therapy delivery, modify device functionality, or affect diagnostic accuracy, putting patient safety at risk.
2. Regulatory Compliance
The FDA requires:
Cybersecurity testing documentation
SBOM validation
Secure update and patch management processes
Risk mitigation evidence
These elements must be included in all 510(k) submissions.
3. Risk Reduction and Liability Prevention
Cybersecurity gaps may result in:
Regulatory penalties
Product recalls
Delayed approvals or market entry
Loss of trust from hospitals and distribution partners
4. Global and Cambodian Regulatory Expectations
Manufacturers in Cambodia targeting international markets must comply with:
FDA premarket cybersecurity guidance
Local security best practices and healthcare cybersecurity guidelines
Cyberintelsys FDA 510(k) Cybersecurity Assessment Methodology
Cyberintelsys follows a comprehensive, FDA-aligned assessment framework to ensure medical devices meet global cybersecurity and regulatory standards.
1. Scoping and Device Ecosystem Analysis
We begin with a detailed assessment of the device ecosystem, including:
Hardware and embedded components
Firmware architecture
Third-party libraries and dependencies
Communication protocols: Wi-Fi, BLE, Zigbee, HL7, DICOM, MQTT, TCP/IP
Integrated web, mobile, and cloud applications
Deliverable: Device architecture documentation, asset mapping, and a scoped testing plan.
2. Vulnerability Assessment (VA)
This includes:
Automated vulnerability scanning
Firmware analysis and reverse engineering
Hardening and configuration review
Encryption and secret management analysis
API and web interface validation
SBOM verification
Output: A detailed vulnerability report with CVSS scoring and mitigation guidance.
3. Penetration Testing (PT)
We simulate real-world cyberattacks across the device ecosystem:
Network and IoMT penetration testing
Wireless protocol exploitation
Firmware exploitation
Cloud platform penetration testing
Mobile application assessment
Backend API and server-side penetration testing
Deliverable: Proof-of-concept (PoC) exploitation reports with impact evidence.
4. Threat Modeling and Cyber Risk Analysis
Using STRIDE, MITRE ATT&CK, and FDA guidance, we analyze:
Attack vectors
Weak points in the device ecosystem
Patient safety risks
Compliance gaps
Output: A full cybersecurity risk assessment aligned with ISO 14971.
5. FDA 510(k) Cybersecurity Documentation Support
Cyberintelsys prepares submission-ready documents, including:
VAPT reports
Cybersecurity risk management file
SBOM and dependency analysis
Secure design and engineering control documentation
Encryption, authentication, and access control evidence
Patch management and secure update policies
All documentation is structured according to FDA 510(k) cybersecurity expectations.
6. Fix Validation and Retesting
After remediation, we conduct retesting to ensure all issues are resolved and controls meet FDA security expectations.
Medical Devices We Support
Cyberintelsys provides FDA 510(k)-aligned cybersecurity assessments for a wide range of devices.
1. Diagnostic Devices
X-ray, MRI, CT systems
Ultrasound machines
Laboratory analyzers
2. Therapeutic Devices
Infusion pumps
Ventilators
Insulin delivery devices
3. Patient Monitoring & IoMT Devices
Wearable health monitors
Remote telemetry systems
Wireless IoMT devices
4. Medical Software & Digital Health Platforms
Cloud healthcare platforms
AI/ML medical applications
Mobile health applications
EHR-integrated systems
Why Choose Cyberintelsys in Cambodia?
Cyberintelsys is a trusted medical device cybersecurity and regulatory compliance partner.
Key Advantages
CREST-certified cybersecurity professionals
Deep FDA, ISO, and IEC regulatory experience
Expertise in embedded systems, firmware, cloud, mobile, and IoMT
Submission-ready reporting aligned with 510(k) cybersecurity requirements
Strong healthcare cybersecurity expertise
Fast support for Cambodian medical device manufacturers
Benefits of Cyberintelsys Medical Device Cybersecurity Services
Faster FDA 510(k) approval timelines
Strengthened device cybersecurity posture
Reduced vulnerabilities and operational risks
Improved trust from hospitals and healthcare partners
Faster readiness for global market entry
Conclusion
As medical devices become more connected and software-driven, FDA 510(k) cybersecurity compliance is essential for manufacturers targeting the U.S. market. Cyberintelsys delivers complete, CREST-accredited cybersecurity assessments tailored for medical device companies in Cambodia. With expertise in VAPT, firmware security, SBOM validation, threat modeling, and FDA-aligned documentation, Cyberintelsys ensures your devices meet the highest global cybersecurity standards and are fully prepared for FDA 510(k) submission.
